Standard neoadjuvant therapy

DRUG2 trials

Sponsors

Shanghai Zhongshan Hospital, Pengfei Qiu

Conditions

Breast CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Gastric / Gastroesophageal Junction Adenocarcinoma

Phase 2

Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)

Not yet recruitingNCT07257380

Shanghai Zhongshan HospitalGastric / Gastroesophageal Junction Adenocarcinoma

Start: 2025-12-30End: 2029-12-30Target: 90Updated: 2025-12-02

Phase 3

RaSOLVE: 125I Radioactive Seed Marking Effects on Pathological Complete Response Rate and Prognosis Post-Neoadjuvant Therapy in Early/Advanced Breast Cancer

Not yet recruitingNCT07269691

Pengfei QiuBreast Cancer, Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Start: 2025-12-01End: 2027-12-01Target: 194Updated: 2025-12-08